机构:[1]Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen 5 18020, China.深圳市康宁医院深圳市人民医院深圳医学信息中心[2]Dongguan Maternal and Child Health Care Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Dongguan 523125, Guangdong, China[3]Chinese Medicine Research Institute, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, China.[4]Department of Pediatric Intensive Care Unit, Dongguan Children's Hospital Affiliated to Guangdong Medical University, Dongguan 523125, China.[5]State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, P. R. China.
This work was supported by the National Key Research and Development Program of
China (2020YF A0908000 and 2022YFC2303600); the Innovation Team and Talents
Cultivation Program of National Administration of Traditional Chinese Medicine (No:
ZY YCXTD-C-202002); Establishment of Sino-Austria “Belt;andRoad” Joint
Laboratory on Traditional Chinese Medicine for Severe Infectious Diseases and Joint
Research (2020YFE0205 100); the National Natural Science Foundation of China
(82074098, 8184 1001, 82374063), the F undamental Research Funds for the Central
Public Welfare Research Institutes (ZZ13-ZD-07, ZXKT1 8003, ZZ14-YQ-050, ZZ14-
ND-010,ZZ15-ND-10, ZZ14-FL-002,ZZ14-YQ059 and ZZ15-YQ-063),
the Fundamental Research Funds for the Central public welfare research institutes (ZZ 1 3-
ZD-07),and Shenzhen Science and Technology Innovation Commission(JCYJ20210324115800001,
JCYJ202 10324114014039 and JCYJ202208181026 13029), National Key R&D Program of China Key projects for international cooperation on science, technology and innovation (2020Y FE0205100),
the Shenzhen Medical Research Fund of Shenzhen Medical Academy of Research and
Translation (B2302051), the Distinguished Expert Project of Sichuan Province Tianfu
Scholar (CW202002) and support from State Key Laboratory for Quality Ensurance
and Sustainable Use of Dao-di Herbs. Guangdong-Dongguan Joint Fund Regional
Cultivation Project (202 1B1515140033), Dongguan Science and Technology of Social
Development Program (20221800905732).
语种:
外文
高被引:
被引次数:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|1 区医学
小类|2 区肿瘤学
最新[2025]版:
大类|1 区医学
小类|2 区肿瘤学
第一作者:
第一作者机构:[1]Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen 5 18020, China.[2]Dongguan Maternal and Child Health Care Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Dongguan 523125, Guangdong, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen 5 18020, China.[2]Dongguan Maternal and Child Health Care Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Dongguan 523125, Guangdong, China[3]Chinese Medicine Research Institute, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, China.[4]Department of Pediatric Intensive Care Unit, Dongguan Children's Hospital Affiliated to Guangdong Medical University, Dongguan 523125, China.[5]State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, P. R. China.[*1]Department of Pulmonary and Critical Care Medicine, Shenzhen Institute of Respiratory Diseases, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital ,First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen 518020, China[*2]State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, P. R. China.[*3]Department of Pediatric Intensive Care Unit, Dongguan Children's Hospital Affiliated to Guangdong Medical University, Dongguan 523125, China
推荐引用方式(GB/T 7714):
Chen Pengchen,Zhong Xiaoru,Song Yali,et al.Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells[J].Cancer Letters.2024,216622.doi:10.1016/j.canlet.2024.216622.
APA:
Chen Pengchen,Zhong Xiaoru,Song Yali,Zhong Wenbin,Wang Sisi...&Zhang Wei.(2024).Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells.Cancer Letters,,
MLA:
Chen Pengchen,et al."Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells".Cancer Letters .(2024):216622